PMS AND PMDD

Exploring the diagnosis and treatment of premenstrual dysphoric disorder in the US healthcare system: a qualitative investigation.

Chan K, Rubtsova AA, Clark CJ.

BMC Women’s Health. 2023 May 17;23(1):272.

Participant experiences demonstrated that much of the diagnostic and treatment processes were burdened on the patient, and that successful navigation within the healthcare system was dependent on high levels of self-advocacy.

Does Symptom-Onset Treatment With Sertraline Improve Functional Impairment for Individuals With Premenstrual Dysphoric Disorder?: A Randomized Controlled Trial.

Yonkers KA, Altemus M, Gilstad-Hayden K, Kornstein SG, Gueorguieva R.

J Clin Psychopharmacol. 2023 Jul-Aug 01;43(4):320-325.

Only the relationship functioning significantly improved with active treatment between baseline and the end of the second cycle.

INFERTILITY AND MENTAL HEALTH

No articles this week

PSYCHIATRIC ILLNESS DURING PREGNANCY

Sleep and its association with depressive and anxiety symptoms during the last weeks of pregnancy: A population-based study.

Loret de Mola C, Carpena MX, Dias IM, Meucci R, Goicochea-Romero A, Cesar J.

SleepHealth. 2023 Jun 28:S2352-7218(23)00091-8.

Participants with vespertine chronotype or shorter sleep duration are more likely to have depressive symptoms. Those who took more time to fall asleep or get out of bed were more likely to have both anxiety and depressive symptoms, but the association was stronger for depressive symptoms.

Prenatal depressive symptoms are associated with altered structural brain networks in infants and moderated by infant sleep.

Donnici C, Tomfohr-Madsen L, Long X, Manning KY, Giesbrecht G, Lebel C.

J Affect Disorder. 2023 Jun 28;339:118-126.

Prenatal depressive symptoms appear to impact early topological development in brain networks important for emotion regulation. In the limbic network, sleep duration moderated this relationship, suggesting sleep may play a role in infant brain network development.

Consensus recommendations for the assessment and treatment of perinatal obsessive-compulsive disorder (OCD): A Delphi study.

Mulcahy M, Long C, Morrow T, Galbally M, Rees C, Anderson R.

Arch Women’s Ment Health. 2023 Jun;26(3):389-399.

This study is the first to collate and outline a set of clinical best practice recommendations, developed using the consensus perspectives of both individuals with lived experience and professionals with relevant expertise, for supporting individuals with perinatal OCD and their families.

MEDICATIONS AND PREGNANCY

Antidepressant treatment in pregnancy: a Danish registry linkage study in pregnant women with pre-existing obsessive-compulsive disorder.

Trinh NTH, Semark BD, Munk-Olsen T, Liu X, Thapa SB, Yilmaz Z, Petersen LV, Lupattelli A. Translate Psychiatry. 2023 Jun 23;13(1):223.

Fetal SSRI antidepressant exposure and infant sleep: Findings from the MPEWS pregnancy cohort study.

Galbally M, Watson SJ, Nguyen T, Boyce P.

Infant Behav Dev. 2023 Jun 28;72:101849.

The antidepressants sertraline, escitalopram and citalopram were not associated with increased infant waking or waking time. However, sertraline was associated with longer time for an infant to go to sleep.

Ascertainment of malformations in pregnancy registries: Lessons learned in the North American AED Pregnancy Registry.

Holmes LB, Quinn M, Conant S, Lyons A, Hauser WA, Yerby M, Hernandez-Diaz S.

Birth Defects Res. 2023 Jun 30.

POSTPARTUM PSYCHIATRIC ILLNESS

A systematic review of patient-reported outcome measures used in maternal postpartum anxiety.

O’Carroll J, Ando K, Yun R, Panelli D, Nicklin A, Kennedy N, Carvalho B, Blake L, Coker J, Kaysen D, Sultan P.

Am J Obstet Gynecol MFM. 2023 Jul 2:101076.

A total of 28 studies evaluating 13 instruments in 10,570 patients were included. Five instruments receiving a class A recommendation (recommended for use). Postpartum Specific Anxiety Scale, Postpartum Specific Anxiety Scale Research Short Form, Postpartum Specific Anxiety Scale Research Short Form Covid, Postpartum Specific Anxiety Scale-Persian and State-Trait Anxiety Inventory demonstrated adequate content validity and sufficient internal consistency.

A 5 years’ experience of a parent-baby day unit: impact on baby’s development.

Moureau A, Cordemans L, Gregoire C, Benoît P, Delvenne V.

Front Psychiatry. 2023 Jun 15;14:1121894.

Parent-baby day unit leads to positive outcomes in clinical situations with anxio-depressive parents, relational withdrawal of the babies, functional problems of the babies but not when a significant impact on the development of the baby already exists.

MEDICATIONS AND BREASTFEEDING

No articles this week

PERINATAL SUBSTANCE USE

No articles this week

MATERNAL MENTAL HEALTH AND CHILD OUTCOMES

Association of severe maternal morbidity with bonding impairment and self-harm ideation: A multicenter prospective cohort study.

Terada S, Fujiwara T, Sugawara J, Maeda K, Satoh S, Mitsuda N.

J Affect Disorder. 2023 Oct 1;338:561-568.

Women with severe obstetric complications reported more problems with bonding, which was partially mediated by NICU admission. Psychotherapy to support parent-infant relationships is necessary for women with SMM.

Examining the implications of the developmental timing of maternal trauma for prenatal and newborn outcomes.

Kaliush PR, Kerig PK, Raby KL, Maylott SE, Neff D, Speck B, Molina NC, Pappal AE, Parameswaran UD, Conradt E, Crowell SE.

Infant Behav Dev. 2023 Jul 1;72:101861.

Lifetime traumatic experiences were associated with multiple prenatal maternal health outcomes, including depression, anxiety, emotion dysregulation, and pregnancy complications. Pregnant women’s experiences with childhood trauma, but not adult or prenatal trauma, predicted higher neurobehavioral attention scores among female newborns.

MENOPAUSE AND MENTAL HEALTH

Effects of sleep fragmentation and estradiol decline on cortisol in a human experimental model of menopause.

Cohn AY, Grant LK, Nathan MD, Wiley A, Abramson M, Harder JA, Crawford S, Klerman EB, Scheer FAJL, Kaiser UB, Rahman SA, Joffe H.

J Clin Endocrinol Metab. 2023 May 19:dgad285.

Sleep fragmentation, commonly seen in menopausal women, may disrupt the HPA axis, which in turn may lead to adverse health effects as women age.

OTHER TOPICS IN WOMEN’S MENTAL HEALTH

No articles this week